Trial of a Non-pharmacological Intervention to Prevent Delirium Among Elderly In-patients
NCT ID: NCT03158909
Last Updated: 2020-01-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
284 participants
INTERVENTIONAL
2020-01-15
2020-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Predicting Delirium by Attentional Dysfunction
NCT03988179
Nursing Assistant Intervention to Prevent Delirium in Nursing Homes
NCT02994979
Prophylactic Environmental Management of Delirium
NCT01356810
Screening for Delirium in Older Inpatients
NCT05690672
A Software to Prevent Delirium (PREVEDEL) in Hospitalized Older Adults
NCT05108207
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The aim of this study is evaluate the effect of earplugs and eyemask for delirium prevention among elderly in-patients of a brazilian university hospital. This will be a partially blinded clinical trial, in wich both control and intervention group will receive information about orientation to time and space every evening, and intervention group will also receive earplugs and eyemask for use during the night. The primary outcome will be the occurrence of delirium.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Interventional
Patients in this group will receive eyemask and earplugs, for use during the night, and orientations about space and time, every night.
Eyemask and earplugs
Eyemask and earplugs for use during the night, to improve sleep.
Orientation about space and time
Information and orientation about space and time, given every night.
Orientation about space and time
This group will receive orientations about space and time olny, every night.
Orientation about space and time
Information and orientation about space and time, given every night.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Eyemask and earplugs
Eyemask and earplugs for use during the night, to improve sleep.
Orientation about space and time
Information and orientation about space and time, given every night.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Understand and consent in participating in the study and sign the consent form.
* 60 years of age, or older.
* Visual and auditory acuity sufficient to perform cognitive tests.
Exclusion Criteria
* Glasgow Coma Scale less than 15 in the selection visit.
* PRISMA-7 ≤3 patient will be excluded.
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital de Clinicas de Porto Alegre
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Artur S Schuh, PhD
Role: PRINCIPAL_INVESTIGATOR
Hospital de Clínicas de Porto Alegre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hospital de Clínicas de Porto Alegre
Porto Alegre, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
160529
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.